Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. (SHA:600613)
China
· Delayed Price · Currency is CNY 6.41
+0.01 (0.16%)
Mar 10, 2026, 9:55 AM CST
SHA:600613 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | 62.34 | 71.39 | 57 | 48.55 | 69.62 | -341.2 | Upgrade
|
| Depreciation & Amortization | 90.85 | 90.85 | 93.29 | 96.43 | 66.11 | 52.88 | Upgrade
|
| Other Amortization | 1.78 | 1.78 | 0.75 | 0.81 | 2.11 | 4.8 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.12 | 0.12 | -0.27 | 5.17 | 0 | -0 | Upgrade
|
| Asset Writedown & Restructuring Costs | 1.72 | 1.72 | 55.78 | 2.78 | 27.89 | 161.21 | Upgrade
|
| Loss (Gain) From Sale of Investments | -1.23 | -1.23 | -1.71 | -1.77 | -28.11 | -1.17 | Upgrade
|
| Provision & Write-off of Bad Debts | 16.2 | 16.2 | -34.98 | 5.34 | -15.83 | 110.21 | Upgrade
|
| Other Operating Activities | 13.71 | 28.39 | 20 | 27.03 | -1.8 | 65.04 | Upgrade
|
| Change in Accounts Receivable | 100.43 | 100.43 | 100.94 | -25.11 | -231.77 | 148.8 | Upgrade
|
| Change in Inventory | 9.47 | 9.47 | -22.85 | -26.64 | -3.25 | -39.12 | Upgrade
|
| Change in Accounts Payable | -110.68 | -110.68 | -59.47 | 186.91 | 294.47 | -40.59 | Upgrade
|
| Operating Cash Flow | 184.05 | 207.79 | 215.59 | 319.23 | 184.26 | 99.1 | Upgrade
|
| Operating Cash Flow Growth | -20.37% | -3.62% | -32.47% | 73.25% | 85.94% | -22.75% | Upgrade
|
| Capital Expenditures | -44.37 | -36.39 | -24.51 | -26.64 | -85.96 | -96.31 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.59 | 0.39 | 4.3 | 0.17 | 0.12 | 0.08 | Upgrade
|
| Divestitures | - | - | - | - | 1.67 | - | Upgrade
|
| Investment in Securities | -189.97 | 0.03 | -20 | 0.3 | -3.11 | 1.03 | Upgrade
|
| Other Investing Activities | 1.44 | 1.05 | 0.46 | 1.7 | 1.69 | 1.12 | Upgrade
|
| Investing Cash Flow | -232.31 | -34.92 | -39.75 | -24.47 | -85.58 | -94.08 | Upgrade
|
| Long-Term Debt Issued | - | 32 | 28.86 | 23.78 | 8.15 | 79.72 | Upgrade
|
| Total Debt Issued | 32 | 32 | 28.86 | 23.78 | 8.15 | 79.72 | Upgrade
|
| Long-Term Debt Repaid | - | -74.9 | -87.88 | -86.76 | -90.47 | -193.61 | Upgrade
|
| Total Debt Repaid | -85.88 | -74.9 | -87.88 | -86.76 | -90.47 | -193.61 | Upgrade
|
| Net Debt Issued (Repaid) | -53.88 | -42.9 | -59.02 | -62.98 | -82.33 | -113.89 | Upgrade
|
| Common Dividends Paid | -90.74 | -64.18 | -66.29 | -68.97 | -3.97 | -5.83 | Upgrade
|
| Other Financing Activities | -49.59 | -0.5 | 9.19 | -1.99 | - | - | Upgrade
|
| Financing Cash Flow | -194.21 | -107.58 | -116.12 | -133.93 | -86.3 | -119.72 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.01 | -0.18 | 0 | 0 | -0 | -0 | Upgrade
|
| Net Cash Flow | -242.46 | 65.1 | 59.72 | 160.82 | 12.39 | -114.7 | Upgrade
|
| Free Cash Flow | 139.68 | 171.39 | 191.08 | 292.59 | 98.3 | 2.79 | Upgrade
|
| Free Cash Flow Growth | -30.46% | -10.30% | -34.70% | 197.65% | 3421.80% | -94.56% | Upgrade
|
| Free Cash Flow Margin | 7.42% | 8.37% | 8.16% | 12.25% | 4.27% | 0.15% | Upgrade
|
| Free Cash Flow Per Share | 0.25 | 0.31 | 0.37 | 0.54 | 0.18 | 0.01 | Upgrade
|
| Cash Income Tax Paid | 152.29 | 166.89 | 229.78 | 196.1 | 205.93 | 199.18 | Upgrade
|
| Levered Free Cash Flow | 97.09 | 180.74 | 127.79 | 235.59 | 2.14 | 256.79 | Upgrade
|
| Unlevered Free Cash Flow | 103.97 | 188.74 | 137.02 | 246.44 | 7.35 | 259.87 | Upgrade
|
| Change in Working Capital | -1.42 | -1.42 | 25.72 | 134.88 | 64.28 | 47.35 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.